Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Medtronic
Baxter
Moodys
McKinsey

Last Updated: September 26, 2022

Claims for Patent: 6,716,814


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Summary for Patent: 6,716,814
Title: Enhancing solubility of iron amino acid chelates and iron proteinates
Abstract:A method of enhancing the solubility of iron amino acid chelates and iron proteinates is disclosed. This is accomplished by mixing an effective amount of an organic acid solubilizing agent into existing iron amino acid chelates or iron proteinates. The iron amino acid chelates and iron proteinates may have a ligand to metal molar ratio from about 1:1 to 4:1, preferably 2:1 to 3:1.
Inventor(s): Ericson; Clayton (Morgan, UT), Ashmead; H. DeWayne (Fruit Heights, UT)
Assignee: Albion International, Inc. (Clearfield, UT)
Application Number:09/931,397
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,716,814
Patent Claims: 1. A method of enhancing the solubility of iron amino acid chelates and iron proteinates comprising admixing an effective amount of an organic acid solubilizing agent with an iron amino acid chelate or iron proteinate having a ligand to metal molar ratio from about 1:1 to 4:1 to form a mixture of iron amino acid chelate or iron proteinate and organic acid, wherein the solubilizing agent to iron content weight ratio is from about 5:1 to 1:1.

2. A method as in claim 1 wherein the ligand to metal molar ratio is from about 2:1 to 3:1.

3. A method according to claim 1 wherein said solubilizing agent is selected from the group consisting of citric acid, ascorbic acid, acetic acid, lactic acid, malic acid, succinic acid, and combinations thereof.

4. A method according to claim 1 wherein said solubilizing agent is acetic acid and wherein the acetic acid to iron content weight ratio is from about 3:1 to 1:1.

5. A method according to claim 1 wherein said solubilizing agent is ascorbic acid and wherein the ascorbic acid to iron content weight ratio is from about 5:1 to 1:1.

6. A method according to claim 1 wherein said solubilizing agent is citric acid and wherein the citric acid to iron content weight ratio is from about 3:1 to 1:1.

7. A method according to claim 1 wherein said solubilizing agent is lactic acid and wherein the lactic acid to iron content weight ratio is from about 3:1 to 1:1.

8. A method according to claim 1 wherein said solubilizing agent is malic acid and wherein the malic acid to iron content weight ratio is from about 3:1 to 1:1.

9. A method according to claim 1 wherein said solubilizing agent is succinic acid and wherein the succinic acid to iron content weight ratio is from about 3:1 to 1:1.

10. A method according to claim 1 wherein said solubilizing agent is a combination of ascorbic acid and citric acid at a molar ratio from 10:1 to 1:1, and wherein the iron content to solubilizing agent ratio is from about 5:1 to 1:1 by weight.

11. A method according to claim 1 wherein said iron amino acid chelate or iron proteinate and said solubilizing agent are in a particulate form and wherein said mixing step produces a particulate homogenous mixture prior to hydration.

12. A method according to claim 11 wherein said particulate mixture is hydrated.

13. A method according to claim 1 wherein said iron amino acid chelate or iron proteinate and said solubilizing agent are hydrated prior to said admixing step.

14. A method according to claim 1 wherein said iron amino acid chelate or iron proteinate is in a particulate form and wherein said solubilizing agent is in a liquid form when admixed.

15. A method according to claim 1 wherein said iron amino acid chelate or iron proteinate is in a liquid form and wherein said solubilizing agent is in a particulate form when mixed.

16. A method of enhancing the solubility of an iron amino acid chelate- or iron proteinate-sugar complex comprising admixing an effective amount of an organic acid solubilizing agent into said iron amino acid chelate- or iron proteinate-sugar complex to form a mixture of iron amino acid chelate- or iron proteinate-sugar complex and organic acid, wherein the solubilizing agent to iron content ratio is from about 4:1 to 1:1 by weight.

17. A method according to claim 16 wherein said iron amino acid chelate- or iron proteinate-sugar complex comprises iron, an amino acid or proteinate ligand, and a sugar, wherein said ligand to iron molar ratio is from about 1:1 to 4:1 and wherein said sugar content to said iron content molar ratio is from about 1:1 to 3:1.

18. A method according to claim 17 wherein said ligand to iron molar ratio is from about 2:1 to 3:1.

19. A method according to claim 17 wherein said solubilizing agent is selected from the group consisting of citric acid, ascorbic acid, acetic acid, lactic acid, malic acid, succinic acid, and combinations thereof.

20. A method according to claim 17 wherein said sugar is selected from the group consisting of glucose, sucrose, and combinations thereof.

21. A method of enhancing the solubility of an iron amino acid chelate or iron proteinate-containing aqueous solution in the presence of a sugar comprising admixing an effective amount of an organic acid solubilizing agent into said iron amino acid chelate or iron proteinate aqueous solution to form a mixture of iron amino acid chelate or iron proteinate and organic acid prior to adding said sugar to said solution.

22. A method according to claim 21 wherein said iron amino acid chelate or iron proteinate has a ligand to iron molar ratio from about 1:1 to 4:1 and wherein said sugar content to said iron content molar ratio is from about 1:1 to 3:1.

23. A method according to claim 22 having a ligand to iron molar ratio from about 2:1 to 3:1.

24. A method according to claim 21 wherein said solubilizing agent is selected from the group consisting of citric acid, ascorbic acid, acetic acid, lactic acid, malic acid, succinic acid, and combinations thereof.

25. A method according to claim 21 wherein the solubilizing agent to iron content ratio is from about 4:1 to 1:1 by weight.

26. A method according to claim 21 wherein said sugar is selected from the group consisting of glucose, sucrose, and combinations thereof.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Boehringer Ingelheim
Johnson and Johnson
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.